Biostem Technologies Inc
OTC:BSEM

Watchlist Manager
Biostem Technologies Inc Logo
Biostem Technologies Inc
OTC:BSEM
Watchlist
Price: 13.5 USD 0.93% Market Closed
Market Cap: 224.8m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

BSEM Price Targets Summary
Biostem Technologies Inc

Wall Street analysts forecast BSEM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BSEM is 36.21 USD with a low forecast of 35.86 USD and a high forecast of 37.28 USD.

BSEM Lowest Forecast
Wall Street Target
35.86 USD
166% Upside
BSEM Average Forecast
Wall Street Target
36.21 USD
168% Upside
BSEM Highest Forecast
Wall Street Target
37.28 USD
176% Upside
Lowest
Price Target
35.86 USD
166% Upside
Average
Price Target
36.21 USD
168% Upside
Highest
Price Target
37.28 USD
176% Upside
Biostem Technologies Inc Competitors:
Price Targets
GS71
GSK plc
19% Upside
4151
Kyowa Kirin Co Ltd
13% Upside
PHAT
Phathom Pharmaceuticals Inc
100% Upside
T
600867
Tonghua Dongbao Pharmaceutical Co Ltd
29% Upside
GS71
GSK plc
19% Upside
4151
Kyowa Kirin Co Ltd
13% Upside
PHAT
Phathom Pharmaceuticals Inc
100% Upside
T
600867
Tonghua Dongbao Pharmaceutical Co Ltd
29% Upside
600750
Jiang Zhong Pharmaceutical Co Ltd
38% Upside
002653
Haisco Pharmaceutical Group Co Ltd
43% Upside
KLBF
Kalbe Farma Tbk PT
12% Upside
K
4521
Kaken Pharmaceutical Co Ltd
23% Upside

Revenue
Forecast

Revenue Estimate
Biostem Technologies Inc

For the last 13 years the compound annual growth rate for Biostem Technologies Inc's revenue is 52%. The projected CAGR for the next 2 years is 21%.

52%
Past Growth
21%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Biostem Technologies Inc

The compound annual growth rate of Biostem Technologies Inc's operating income for the next 2 years is 51%.

N/A
Past Growth
51%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Biostem Technologies Inc

The compound annual growth rate of Biostem Technologies Inc's net income for the next 2 years is 69%.

N/A
Past Growth
69%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
BSEM intrinsic value, competitors valuation, and company profile.
DCF Valuation
BSEM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BSEM stock valuation using valuation multiples.
Wall Street Estimates
BSEM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BSEM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BSEM's stock price target?
Price Target
36.21 USD

According to Wall Street analysts, the average 1-year price target for BSEM is 36.21 USD with a low forecast of 35.86 USD and a high forecast of 37.28 USD.

What is Biostem Technologies Inc's Revenue forecast?
Projected CAGR
21%

For the last 13 years the compound annual growth rate for Biostem Technologies Inc's revenue is 52%. The projected CAGR for the next 2 years is 21%.

What is Biostem Technologies Inc's Operating Income forecast?
Projected CAGR
51%

The compound annual growth rate of Biostem Technologies Inc's operating income for the next 2 years is 51%.

What is Biostem Technologies Inc's Net Income forecast?
Projected CAGR
69%

The compound annual growth rate of Biostem Technologies Inc's net income for the next 2 years is 69%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 264,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.